ESSA Pharma (EPIX) to Delay Offering Until Results From Higher Dose in Phase 1 Trial of EPI-506
Tweet Send to a Friend
ESSA Pharma Inc. (NASDAQ: EPIX) today provided a further update on its intention to pursue an equity offering. As outlined ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
